The Traderszone Network

Published in TZ Latest News 2 December, 2014 by The TZ Newswire Staff

Japan’s Otsuka to buy Avanir for $3.5 billion ahead of patent cliff

(Reuters) – Japanese drugmaker Otsuka Holdings Co Ltd plans to buy U.S.-based Avanir Pharmaceuticals Inc for about $3.5 billion (2.2 billion pounds) to expand its neurologic drug portfolio ahead of an …